Sign in
4

Changes in Ownership

UNITED THERAPEUTICS Corp Filed Acc 0001106578-26-000173

Chairperson & CEO sold 9,500 shares at an average $587.73 ($5,583,418)

  • Chairperson & CEO acquired 9,500 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

ROTHBLATT MARTINE A · Chairperson & CEO

Table I: Non-derivative

12 lines
Date Transaction Shares Price Value Owned after D/I
2026-10-27 Exercise or conversion : show line 1 in the form 10b5-1 +9,500 $117.76 $1,118,720 333,943 I
2026-10-27 Sale : show line 2 in the form 10b5-1 −89 $582.66 $51,857 333,854 I
2026-10-27 Sale : show line 3 in the form 10b5-1 −807 $583.94 $471,243 333,047 I
2026-10-27 Sale : show line 4 in the form 10b5-1 −1,417 $584.83 $828,703 331,630 I
2026-10-27 Sale : show line 5 in the form 10b5-1 −470 $585.72 $275,287 331,160 I
2026-10-27 Sale : show line 6 in the form 10b5-1 −1,417 $586.93 $831,673 329,743 I
2026-10-27 Sale : show line 7 in the form 10b5-1 −1,320 $587.88 $776,004 328,423 I
2026-10-27 Sale : show line 8 in the form 10b5-1 −1,597 $588.95 $940,547 326,826 I
Open-market sales · 9,500 sh · avg $587.73 · $5,583,418

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-10-27 Exercise or conversion : show line 13 in the form 10b5-1 Stock Option −9,500 147,910 I
Loading xslF345X06/primarydocument.xml…